Review version · Content and translations await hospital approval. Live transaction availability is indicated on the relevant screen.
444 1 349
Nev Hospital

Doç. Dr. Ali Yılmaz

Doç. Dr. Ali Yılmaz

Specialty

Medical oncology

For current appointment options, contact the hospital.

Appointments

Translation draft · Not yet approved by the hospital.

Education

  • Sivas Cumhuriyet University, Faculty of Medicine, 2005.
  • Sivas Cumhuriyet University Faculty of Medicine Hospital, Department of Internal Medicine, 2011–2015.

Professional experience

  • Internal medicine specialist, Bolu İzzet Baysal State Hospital, 2015–2017.
  • Kayseri Erciyes University Faculty of Medicine Hospital, Department of Gastroenterology, 2017–2018.
  • Medical oncology specialist, Department of Medical Oncology, Erzurum Atatürk University Faculty of Medicine Hospital, 2018–2021.
  • Associate professor of medical oncology at Şanlıurfa Mehmet Akif İnan Training and Research Hospital, 2021–2023. Associate professor of medical oncology at Private Nev Hospital, Şanlıurfa, from 2023; listed as ongoing in the source.

Professional memberships

  • Turkish Society of Medical Oncology; European Society for Medical Oncology (ESMO).

National scientific publications — original references

  • YILMAZ ALİ, TEKİN SALİM BAŞOL, BİLİCİ MEHMET, YILMAZ HATİCE (2020). Clinical significance of inflammatory indexes in patients with epithelial ovarian cancer.
  • Acta Oncologica Turcica, 53(3), 402-409., Doi: 10.5505/aot.2020.38981
  • YILMAZ ALİ, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2020). Survival Analysis and Prognostic Factors in Prostate Cancer Patients: A Single Center Experience in Eastern Anatolia.
  • Dicle Tıp Dergisi, 47(4), 796-805., Doi: 10.5798/dicletip.850364
  • MİRİLİ CEM, YILMAZ ALİ, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2019). Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey.
  • Dicle Tıp Dergisi, 46(4), 857-865., Doi: 10.5798/dicletip.579312
Show all entries (12)
  • MİRİLİ CEM, PAYDAŞ SEMRA, YILMAZ ALİ, OĞUL ALİ, BÜYÜKŞİMŞEK MAHMUT, YETİŞİR ABDULLAH EVREN, TOHUMCUOĞLU MERT (2019). Prognostic significance of dynamic inflammatory indexes in cases renal cell cancer treated by tyrosine kinase inhibitor (TKI).
  • ACTA ONCOLOGICA TURCICA, 52(3), 372-378., Doi: 10.5505/aot.2019.08760
  • KAÇAN TURGUT, AKGÜL BABACAN NALAN, KILIÇKAP SAADETTİN, ŞEKER MEHMET METİN, YÜCEL BİRSEN, UNCU TUNAHAN, YILMAZ ALİ (2013). Non-metastatik mide kanserli olgularda prognostik faktörler.
  • Cumhuriyet Tıp Dergisi, 35(3), 326-331., Doi: 10.7197/1305-0028.19
  • AKGÜL BABACAN NALAN, KILIÇKAP SAADETTİN, KAÇAN TURGUT, ŞEKER MEHMET METİN, YÜCEL BİRSEN, YILMAZ ALİ (2013). Port site recurrence of gallbladder cancer after laparoscopic cholecystectomy.
  • Cumhuriyet Tıp Dergisi, 35(2), 286-290., Doi: 10.7197/1305-0028.1981

International scientific publications — original references

  • KARACİN CENGİZ, SUNAR VELİ, URAKÇI ZUHAT, YILMAZ ALİ (2024). Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer. Future Oncol. 2024 Feb;20(4):207-214. doi: 10.2217/fon-2023-0763. Epub 2024 Feb 8.
  • BÜYÜKBAYRAM MEHMET EMİN, HANNARİCİ ZEKERİYA, YILMAZ ALİ, TURHAN AYKUT (2024). Inflammatory parameters in NSCLC with driver mutation. Lung Cancer Manag. 2024 May 16;13(1):LMT66. doi: 10.2217/lmt-2023-0014. eCollection 2024.
  • HANNARİCİ ZEKERİYA, YILMAZ ALİ, BÜYÜKBAYRAM MEHMET EMİN, TURHAN AYKUT, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2022). Lipegfilgrastim may cause hyperleukocytosis. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, Doi: 10.1177/10781552221082645
  • HANNARİCİ ZEKERİYA, YILMAZ ALİ, BÜYÜKBAYRAM MEHMET EMİN, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2021). A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio.
  • Melanoma Research, 31(6), 566-574., Doi: 10.1097/CMR.0000000000000785
  • YILMAZ ALİ, GÖKÇEN PINAR, YILMAZ HATİCE, HÜZMELİ CAN, YILMAZ ABDULKERİM (2021) Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. The Eurasian Journal of Medicine, 53(3), 220-226., Doi: 10.5152/eurasianjmed.2021.20412
Show all entries (26)
  • YILMAZ HATİCE, DEMİRAĞ GÜZİN, YILMAZ ALİ (2021). Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib. Journal of Pharmacy and Pharmaceutical Sciences, 24, 148-152., Doi: 10.18433/jpps31425
  • YILMAZ ALİ, ŞİMŞEK MELİH, HANNARİCİ ZEKERİYA, BÜYÜKBAYRAM MEHMET EMİN, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2021). The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib.
  • Future Oncology, 17(33), 45454559., Doi: 10.2217/fon-2021-0457
  • YILMAZ HATİCE, YILMAZ ALİ, DEMİRAĞ GÜZİN (2021). Prognostic significance of hemoglobin-tored cell distribution width ratio in patients with metastatic renal cancer.
  • Future Oncology, 17(29), 3853-3864., Doi: 10.2217/fon-2021-0040
  • YILMAZ HATİCE, DEMİRAĞ GÜZİN, SÜLLÜ YURDANUR, YILMAZ ALİ (2021). Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 31(5), 546-552., Doi: 10.29271/jcpsp.2021.05.546
  • YILMAZ ALİ, MİRİLİ CEM, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2020). Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 35(2), 351-353., Doi: 10.1007/s00384-019-03454-4
  • YILMAZ ALİ, MİRİLİ CEM, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2020). Possible atezolizumabassociated acute kidney injury and immune thrombocytopenia. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 26(7), 1791-1794., Doi: 10.1177/1078155220913081
  • MİRİLİ CEM, YILMAZ ALİ (2020). Coexistence of anal malignant melanoma and papillary renal cell cancer: An interesting coexistence. Journal of Cancer Research and Therapeutics, 16(1), 189-191., Doi: 10.4103/jcrt.JCRT_370_19
  • YILMAZ ALİ, TEKİN SALİM BAŞOL, BİLİCİ MEHMET, YILMAZ HATİCE (2020). The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer. LUNG, 198(4), 695-704., Doi: 10.1007/s00408-020-00361-2
  • YILMAZ ALİ, YILMAZ HATİCE, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2020). The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer.
  • BIOMARKERS IN MEDICINE, 14(9), 727-738., Doi: 10.2217/bmm-2020-0045
  • YILMAZ ALİ, MİRİLİ CEM, TEKİN SALİM BAŞOL, BİLİCİ MEHMET (2020). The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. IRISH JOURNAL OF MEDICAL SCIENCE, 189(1), 91-102., Doi: 10.1007/s11845-019-02153-x MİRİLİ CEM, KAHRAMAN ÇİĞDEM, YILMAZ ALİ, BİLİCİ MEHMET, TEKİN SALİM BAŞOL, TATAR ABDULGANİ, YAKAR ÖMER, ERCOŞKUN PELİN (2019). Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results. Medical Science and Discovery, 6(12), 327-332., Doi: https://doi.org/10.36472/msd.v6i12.330
  • MİRİLİ CEM, PAYDAŞ SEMRA, KORKMAZ KAPUKAYA TUBA, YILMAZ ALİ (2019). Systemic immuneinflammation index predicting survival outcome in patients with classical Hodgkin lymphoma.
  • BIOMARKERS IN MEDICINE, 13(18), 1565-1575., Doi: 10.2217/bmm-2019-0303
  • YILMAZ ALİ, MİRİLİ CEM, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2019). A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII).
  • JOURNAL OF BUON, 24(5), 2127-2135.
  • MİRİLİ CEM, YILMAZ ALİ, DEMİRKAN SERKAN, BİLİCİ MEHMET, TEKİN SALİM BAŞOL (2019). Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 24(10), 1301-1310., Doi: 10.1007/s10147-019-01461-7
  • HÜZMELİ CAN, CANDAN FERHAN, BAĞCI GÖKHAN, ALAYGUT DEMET, YILMAZ ALİ, GEDİKLİ MUSTAFA ASIM, BAĞCI BİNNUR, TİMÜÇİN MERYEM, SEZGİN İLHAN, KAYATAŞ MANSUR (2017). Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis.
  • CLINICAL RHEUMATOLOGY, 36(11), 2589-2594., Doi: 10.1007/s10067-017-3701-y ŞEKER MEHMET METİN, DEVECİ KÖKSAL, ŞEKER AYŞE, SANCAKDAR ENVER, YILMAZ ALİ, TÜRESİN AHMET KERİM, KAÇAN TURGUT, AKGÜL BABACAN NALAN (2015). Predictive role of neutrophil gelatinase-associated lipocalin in early diagnosis of platin-induced renal injury. Asian Pacific Journal of Cancer Prevention, 16(2), 407-410., Doi: 10.7314/apjcp.2015.16.2.407.